Here's the top 20 list as at 30 September, showing the sub...

Here's the top 20 list as at 30 September, showing the sub holder with 15m shares. Now with 22m shares.

I wonder if any of the other top 20 are accumulating?

This, together with the director buying on market, give me confidence that the company is going somewhere soon.

Still due the following announcements:

- Various updates on commercialization of Oraline
- Commencement of asthma trials with Telethon (due to start Jan 2015)
- Additional biotech acquisition(s)


http://www.news.com.au/national/bre...-on-asthma-genes/story-e6frfku9-1227055621217